KVUE | tickerfilter.com

Fundamental analysis

46%

Profitability 24%

Dept financing 40%

Liquidity 25%

Performance 73%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

0.31%

1 Month

-2.91%

3 Months

7.72%

6 Months

0.57%

1 Year

20.72%

2 Year

-14.46%

Key data

Stock price

$23.01

P/E Ratio

39.68

DAY RANGE

$22.38 - $23.46

EPS

$0.54

52 WEEK RANGE

$17.67 - $24.46

52 WEEK CHANGE

$20.72

MARKET CAP

40.874 B

YIELD

3.80%

SHARES OUTSTANDING

1.915 B

DIVIDEND

$0.205

EX-DIVIDEND DATE

05-14-2025

NEXT EARNINGS DATE

05-06-2025

BETA

-0.11

PUBLIC FLOAT

AVERAGE 10 VOLUME

$19,497,513

AVERAGE 30 VOLUME

$18,997,504

Company detail

CEO: Thibaut Mongon
Region: US
Website: www.jnj.com/kenvue/
Employees: 0
IPO year: 2023

Issue type: Common Stock
Market: NYSE
Industry: Consumer Goods/Perfumes, Cosmetics And Other Toilet Preparations
Sector: Manufacturing

We are the world’s largest pure-play consumer health company by revenue with $15.0 billion in net sales in 2022. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Prior to the completion of this offering, we are a wholly owned subsidiary of Johnson & Johnson. Our principal executive offices are located at 199 Grandview Road, Skillman, NJ.

KVUE - Kenvue Inc.